So when it came time to make the follow-up LP, which turned out to be Sleepy Eyed, Buffalo Tom did a slight about-face rather ...
Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...